SCADA Systems for Pharmaceutical & Life Sciences
How scada systems is delivered for pharmaceutical & life sciences — typical scope, applicable standards, and engineering considerations.
SCADA Systems for Pharmaceutical & Life Sciences
SCADA systems in pharmaceutical and life sciences projects are not “just monitoring software.” They are part of a controlled automation architecture that must support product quality, data integrity, validated operation, traceability, and cybersecurity. In this sector, the scope usually extends from PLC/RTU integration and historian design to alarm management, audit trails, electronic records, and qualification documentation. The engineering challenge is to deliver a system that is reliable for operations, defensible in audits, and maintainable across the asset lifecycle.
How the scope is typically defined
A pharmaceutical SCADA scope normally starts with the user requirements specification (URS) and a risk-based assessment of the process, utility, or facility being automated. Common applications include purified water, WFI, clean steam, HVAC, CIP/SIP skids, fermentation, filling support utilities, and environmental monitoring. The scope should clearly define:
- Process areas and equipment to be supervised
- Control responsibilities between PLC, SCADA, and local instruments
- Alarm classes, operator actions, and escalation rules
- Batch, recipe, and lot-related data requirements
- Data retention, reporting, and electronic signature needs
- Cybersecurity and network segmentation requirements
- Validation deliverables and acceptance criteria
For regulated environments, the automation design must support data integrity expectations such as ALCOA+ principles, even when those are not written as a single IEC clause. In practice, this means secure user access, time synchronization, audit trails, controlled change management, and reliable record retention.
Typical deliverables in a life sciences SCADA project
Deliverables are usually more extensive than in general industry because the system must be engineered for qualification and inspection readiness. Typical packages include:
- URS, functional specification, and control philosophy
- Hardware architecture, network architecture, and I/O list
- Software design specification and tag naming standard
- Alarm philosophy and alarm rationalization records
- Faceplates, mimic screens, trends, and report templates
- Historian configuration and data retention matrix
- Cybersecurity concept, user roles, and access matrix
- Test documents: FAT, SAT, IQ, OQ, and sometimes PQ support
- Traceability matrix linking URS to design and test cases
- As-built documentation, backup images, and maintenance manuals
For systems handling electronic records and signatures, the design should support the intent of FDA 21 CFR Part 11 and comparable EU expectations around integrity and traceability. In European projects, the validation approach is often aligned with GAMP 5 principles and the EU Annex 11 mindset, even though Annex 11 is not an IEC standard.
Applicable standards and where they matter
Several standards commonly influence the design and validation strategy:
- IEC 62443 for industrial automation and control system cybersecurity, especially zones and conduits, account management, and secure remote access
- IEC 61131-3 for PLC programming structure and software portability
- IEC 60204-1 for machine electrical equipment where skids or packaged systems are involved
- EN 60204-1 as the European adoption of machine electrical safety requirements
- ISA-18.2 for alarm management lifecycle and rationalization
- ISA-95 for integration between enterprise and control layers when MES or ERP interfaces are in scope
- NFPA 70 and NFPA 79 when the project is executed for US facilities or multinational standards alignment
Alarm design is one of the most common failure points in life sciences SCADA. ISA-18.2 provides the lifecycle approach, while IEC 62682 is the international equivalent. A practical project decision is whether alarms are merely “events” or whether they are rationalized, prioritized, shelved, and performance-managed. In regulated plants, that distinction matters because nuisance alarms can directly affect batch execution and operator response quality.
Validation and qualification approach
Validation is not a single test; it is a lifecycle activity. A typical sequence is design review, supplier assessment, FAT, site installation checks, SAT, IQ, OQ, and selective PQ support. The extent depends on product criticality and the system’s impact on product quality. Good practice is to define testability in the design phase, not after software freeze.
For example, if a purified water loop requires conductivity trending, the OQ should verify setpoint behavior, alarm thresholds, time-stamped records, sensor failure handling, and historian continuity. If the system uses electronic audit trails, test cases should verify who changed what, when, and why, with secure retention and review capability.
In European delivery models, validation evidence should be traceable and version-controlled. A design decision that improves validation efficiency is to standardize templates for alarms, trends, and reports across all skids and utility systems. This reduces test repetition and simplifies change control.
Common engineering decisions and trade-offs
| Decision area | Typical option | Why it matters in pharma |
|---|---|---|
| SCADA topology | Central server with redundant clients and historian | Supports uptime, review, and batch continuity |
| Control split | PLC executes control; SCADA supervises and records | Improves resilience and limits dependence on HMI availability |
| Data storage | Local historian plus validated backup policy | Protects records and supports audit readiness |
| Cybersecurity | IEC 62443 zone/conduit segmentation | Reduces attack surface and supports NIS2-aligned governance |
| Alarm philosophy | Rationalized, prioritized, and performance-managed alarms | Prevents alarm floods and operator overload |
One frequent decision is whether to implement batch functions in SCADA or in a dedicated MES or batch layer. If the process is relatively simple, SCADA may handle sequence supervision and data capture. For larger GMP operations, batch control often belongs in a more specialized layer to better support recipe management, auditability, and ISA-88-style modularity.
What good delivery looks like
A well-run project is cross-functional: automation, QA, validation, IT/OT cybersecurity, and operations all contribute. The best suppliers work from a documented lifecycle model, keep the software modular, and avoid “black box” shortcuts that are hard to validate later. They also define clear ownership for backups, patching, certificate management, user administration, and periodic review.
From a procurement perspective, the most important questions are not only “Does it work?” but “Can it be validated, maintained, and defended in an inspection?” The answer depends on disciplined scope control, standards-based design, and a traceable test strategy from URS to release.
If you are planning a new SCADA platform or upgrading a regulated utility system, it is worth aligning the scope, standards, and validation model early — discuss your project with us via /contact.
Other industries for SCADA Systems
Other services for Pharmaceutical & Life Sciences
Frequently asked questions
What IEC and EN standards should a SCADA system for pharmaceutical and life sciences facilities comply with on European projects?
For European projects, SCADA architecture and integration are typically designed to align with IEC 62443 for industrial cybersecurity, IEC 61511 where the SCADA system interfaces with safety instrumented functions, and EN 60204-1 / EN 61439 for machine and control panel electrical compliance. In regulated pharma environments, these technical standards are usually implemented alongside GAMP 5 and data integrity expectations to support validation, auditability, and controlled change management.
How should SCADA systems be segmented for GMP areas, utilities, and process equipment in a pharmaceutical plant?
A common engineering approach is to segment SCADA into separate zones for critical process equipment, clean utilities, and non-GMP building systems, with controlled data exchange through industrial DMZs or validated gateways. This supports IEC 62443 zone-and-conduit principles and reduces the risk that a fault, patch, or cybersecurity event in one area impacts validated GMP operations.
What is the recommended alarm management approach for SCADA in life sciences manufacturing?
Alarm design should follow ISA 18.2 and IEC 62682, with rationalization of each alarm’s purpose, priority, cause, operator response, and deadband to avoid nuisance alarms and alarm floods. In pharmaceutical plants, alarms should be tied to process risk and batch impact, not just equipment status, so operators can respond consistently without masking deviations that could affect product quality.
How do you design SCADA historian and batch record integration for FDA- and EU-regulated pharmaceutical operations?
Historian and batch record integration should preserve time-stamped, attributable, and audit-trailed records that support data integrity principles such as ALCOA+, while maintaining validated interfaces between SCADA, MES, and ERP layers. Engineers typically map critical process values, alarms, and operator actions into controlled records with synchronization, backup, and retention rules defined during validation under GAMP 5 and relevant Annex 11 / 21 CFR Part 11 expectations.
What electrical panel and I/O design considerations matter most when building SCADA systems for cleanroom and utility applications?
Control panels should be designed to IEC 61439 for assembly performance, with segregation, heat dissipation, maintainability, and clear terminal identification suitable for GMP maintenance practices. For cleanroom-adjacent installations, enclosure selection, cable entry, and device placement should also support hygienic and contamination-control requirements, while field I/O should be selected for signal integrity, EMC robustness, and serviceability.
How should SCADA cybersecurity be handled on global pharmaceutical projects with remote access and vendor support?
Remote access should be implemented with MFA, least privilege, session recording, and a hardened jump-host or DMZ architecture, consistent with IEC 62443 and widely used industrial security practices. For regulated pharma sites, every remote support path should be documented, approved, and validated so that cybersecurity controls do not compromise audit trails, availability, or change control.
What is the best practice for integrating SCADA with PLCs, analyzers, and building management systems in a life sciences facility?
The preferred approach is to define a clear control hierarchy: PLCs handle deterministic machine and process control, SCADA provides supervisory control and visualization, and BMS or BAS systems remain isolated unless a validated data exchange is required. Using standard protocols such as OPC UA with defined tag lists, time synchronization, and interface testing helps maintain interoperability while meeting IEC 61131-3 programming expectations and project-specific validation requirements.
What documentation do EPC contractors need to deliver a compliant SCADA system for pharmaceutical and life sciences projects?
EPC deliverables should include functional design specifications, network architecture, I/O lists, cause-and-effect matrices, alarm philosophy, cybersecurity risk assessment, FAT/SAT protocols, and validation evidence with traceability to user requirements. For European compliance-focused projects, these documents are typically structured to support IEC 62443, IEC 61511 where applicable, and GMP validation practices under GAMP 5 and EU Annex 11.